Literature DB >> 31229535

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.

Yam Nath Paudel1, Efthalia Angelopoulou2, Christina Piperi3, Vinod R M T Balasubramaniam4, Iekhsan Othman5, Mohd Farooq Shaikh6.   

Abstract

High mobility group box 1 (HMGB1) is a ubiquitous protein, released passively by necrotic tissues or secreted actively by stressed cells. Extracellular HMGB1 is a typical damage-associated molecular pattern (DAMP) molecule which generates different redox types through binding with several receptors and signalling molecules, aggravating a range of cellular responses, including inflammation. HMGB1 is reported to participate in the pathogenesis of inflammatory diseases, through the interaction with pivotal transmembrane receptors, including the receptor for advanced glycation end products (RAGE) and toll-like receptor-4 (TLR-4). This review aims to highlight the role of HMGB1 in the innate inflammatory response describing its interaction with several cofactors and receptors that coordinate its downstream effects. Novel and underexplored HMGB1 binding molecules that have been actively involved in HMGB1-mediated inflammatory diseases/conditions with therapeutic potential are further discussed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DAMP; HMGB1; Inflammation; LPS; Pro-inflammatory; TLR4

Year:  2019        PMID: 31229535     DOI: 10.1016/j.ejphar.2019.172487

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  47 in total

1.  Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages.

Authors:  Mahzad Akbarpour; Emilia Lecuona; Stephen F Chiu; Qiang Wu; Melissa Querrey; Ramiro Fernandez; Félix L Núñez-Santana; Haiying Sun; Sowmya Ravi; Chitaru Kurihara; James M Walter; Nikita Joshi; Ziyou Ren; Scott C Roberts; Alan Hauser; Daniel Kreisel; Wenjun Li; Navdeep S Chandel; Alexander V Misharin; Thalachallour Mohanakumar; G R Scott Budinger; Ankit Bharat
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 2.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 3.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

4.  Nephroprotective effect of gastrodin against lead-induced oxidative stress and inflammation in mice by the GSH, Trx, Nrf2 antioxidant system, and the HMGB1 pathway.

Authors:  Zhi-Kai Tian; Yu-Jia Zhang; Zhao-Jun Feng; Hong Jiang; Chao Cheng; Jian-Mei Sun; Chan-Min Liu
Journal:  Toxicol Res (Camb)       Date:  2021-03-23       Impact factor: 3.524

Review 5.  HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities.

Authors:  Yam Nath Paudel; Efthalia Angelopoulou; Christina Piperi; Iekhsan Othman; Mohd Farooq Shaikh
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

6.  Heme oxygenase-1-modified bone marrow mesenchymal stem cells combined with normothermic machine perfusion to protect donation after circulatory death liver grafts.

Authors:  Huan Cao; Liu Yang; Bin Hou; Dong Sun; Ling Lin; Hong-Li Song; Zhong-Yang Shen
Journal:  Stem Cell Res Ther       Date:  2020-06-05       Impact factor: 6.832

7.  Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice.

Authors:  Shiori Hiramoto; Maho Tsubota; Kaoru Yamaguchi; Kyoko Okazaki; Aya Sakaegi; Yuki Toriyama; Junichi Tanaka; Fumiko Sekiguchi; Hiroyasu Ishikura; Hidenori Wake; Masahiro Nishibori; Huy Du Nguyen; Takuya Okada; Naoki Toyooka; Atsufumi Kawabata
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

Review 8.  Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Authors:  Clare T Johnson; Heather B Bradshaw
Journal:  Cannabis Cannabinoid Res       Date:  2021-06

9.  TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence Pathways.

Authors:  Yan Dong; Hongbao Cao; Rongyuan Cao; Ancha Baranova
Journal:  Front Cell Dev Biol       Date:  2020-05-27

10.  Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes.

Authors:  Ruben Serrano; Daniela Wesch; Dieter Kabelitz
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.